
Reset all filters
01 4Valeant Canada LP
Reset all filters
01 42629988
Reset all filters
01 4ZOLPIDEM TARTRATE
Reset all filters
01 4TABLET (ORALLY DISINTEGRATING)
Reset all filters
01 42019-09-24
Patent Expiration Date : 2019-09-24
Date Granted : 2014-01-07
Brand Name : SUBLINOX
Patent Number : 2629988
Filing Date : 1999-09-24
Strength per Unit : 10 mg
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2019-09-24
Date Granted : 2014-01-07
Patent Expiration Date : 2019-09-24
Date Granted : 2014-01-07
Brand Name : SUBLINOX
Patent Number : 2629988
Filing Date : 1999-09-24
Strength per Unit : 10 mg
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Human Or VET : Human
Route of Administration : SUBLINGUAL
Patent Expiration Date : 2019-09-24
Date Granted : 2014-01-07
Patent Expiration Date : 2019-09-24
Date Granted : 2014-01-07
Brand Name : SUBLINOX
Patent Number : 2629988
Filing Date : 1999-09-24
Strength per Unit : 5 mg
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2019-09-24
Date Granted : 2014-01-07
Patent Expiration Date : 2019-09-24
Date Granted : 2014-01-07
Brand Name : SUBLINOX
Patent Number : 2629988
Filing Date : 1999-09-24
Strength per Unit : 5 mg
Dosage Form : TABLET (ORALLY DISINTEGRATING)
Human Or VET : Human
Route of Administration : SUBLINGUAL
Patent Expiration Date : 2019-09-24
Date Granted : 2014-01-07